| [X] | ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|-----|--------------------------------------------------------------------------------|

| [   ] | TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|----------------------|------------------------------------------------------------------------------------|

| Delaware                        | 11-2871434          |
|---------------------------------|---------------------|
| (State or other jurisdiction of | (IRS Employer       |
| incorporation or organization)  | Identification No.) |

| 180 Linden Avenue, Westbury, New York    | 11590      |
|------------------------------------------|------------|
| (Address of Principal Executive Offices) | (Zip Code) |

----

----

|                                                                                                                                                                                                            | Page   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
|                                                                                                                                                                                                            |   |
| ITEM 10 – DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE                                                                                                                                          | 1      |
| ITEM 11 - EXECUTIVE COMPENSATION                                                                                                                                                                                | 4      |
| ITEM 12 - SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND                   RELATED STOCKHOLDER MATTERS | 6      |
| ITEM 13 - CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE                                                                                                                              | 9      |
| ITEM 14 - PRINCIPAL ACCOUNTING FEES AND SERVICES                                                                                                                                                                | 10     |
|                                                                                                                                                                                                            |   |

----

ITEM 10 – DIRECTORS

| Name of Director                     | Age    | Principal Occupation                                        | Director Since |
|--------------------------------------|--------|-------------------------------------------------------------|----------------|
| Simon Srybnik                        | 95     | Chairman of the Board and Director                          | June, 2007     |
| David Lieberman                      | 66     | Vice Chairman of the Board and Director                     | February, 2011 |
| Jun Ma                               | 48     | President and Chief  Executive  Officer | June, 2007     |
| Behnam Movaseghi (2)                 | 58     | Director                                                    | July, 2007     |
| Edgar Rios                           | 59     | Director                                                    | February, 2011 |
| William Dempsey                      | 57     | Director                                                    | June, 2010     |
| Peter C. Castle (1) (2)              | 43     | Director                                                    | August, 2010   |
|                                 |   |                                                        |           |
|                                 |   |                                                        |           |
| (1) Member of the Audit Committee    |   |                                                        |           |
| (2) Member of Compensation Committee |   |                                                        |

----

----

    -  9 meetings of the Board of Directors 
    -  4 meetings of the Audit Committee 

|               |   |   |   |                                               |
|--------------------|--------|--------|--------|----------------------------------------------------|
| Name of Officer    |   | Age    |   | Position held with the Company                     |
| Jun Ma, PhD        |   | 48     |   | President, Chief Executive Officer and Director    |
| Michael J. Beecher |   | 66     |   | Chief Financial Officer                            |
| Jonathan P. Newton |   | 50     |   | Vice President of Finance and Controller           |
| John C.K. Hui, PhD |   | 65     |   | Senior Vice-President and Chief Technology Officer |

----

ITEM 11 -

|   Name and Principal Position                        |   |   Year |   |    Salary ($) |   |    Bonus ($) |   |   Stock Awards ($) (1) |   |   Option Awards ($) (1) |   | Non-Equity Incentive Plan Compensation ($) |   | Nonqualified Deferred Compensation Earnings ($) |   | All Other Compensation ($) (2) |   | Total ($) |   |
|----------------------------------------------------------------|--------|------------------|--------|-------------------------|--------|------------------------|--------|-----------------------------|--------|------------------------------|--------|--------------------------------------------|--------|-------------------------------------------------|--------|--------------------------------|--------|-----------|--------|
| Jun Ma, PhD                                                    |   | 2011             |   | 144,046                 |   | -                      |   | 105,000                     |   | -                            |   |                                       |   |                                            |   | -                              |   | 249,046   |   |
| Chief Executive Officer (3)                                    |   | 2010             |   | 148,471                 |   | -                      |   | 25,000                      |   | 20,000                       |   | -                                          |   | -                                               |   | -                              |   | 193,471   |   |
| Jonathan P. Newton                                             |   | 2011             |   | 105,000                 |   | -                      |   | 31,500                      |   | -                            |   | -                                          |   | -                                               |   | 210                            |   | 136,710   |   |
| Vice President of Finance    and Controller (4) |   |             |   |                    |   |                   |   |                        |   |                         |   |                                       |   |                                            |   |                           |   |
| John C. K. Hui                                                 |   | 2011             |   | 144,209                 |   | -                      |   | -                           |   | -                            |   | -                                          |   | -                                               |   | 1,193                          |   | 145,402   |   |
| Senior Vice President and                                      |   | 2010             |   | 157,151                 |   | -                      |   | 20,000                      |   | -                            |   | -                                          |   | -                                               |   | 886                            |   | 178,037   |   |
|  Chief Technology Officer                                 |   |             |   |                    |   |                   |   |                        |   |                         |   |                                       |   |                                            |   |                           |   |      |   |
| (Chief Executive Officer) (5)                                  |   |             |   |                    |   | -                      |   |                        |   |                         |   |                                       |   |                                            |   |                           |   |      |   |
| W. Brent Barron                                                |   | 2011             |   | 270,000                 |   | 60,750                 |   | 17,100                      |   | -                            |   | -                                          |   | -                                               |   | 963                            |   | 348,813   |   |
| Chief Operating Officer -                                      |   | 2010             |   | 45,000                  |   | -                      |   | -                           |   | -                            |   | -                                          |   | -                                               |   | -                              |   | 45,000    |   |
| VasoHealthcare (6)                                             |   |             |   |                    |   |                   |   |                        |   |                         |   |                                       |   |                                            |   |                           |   |      |   |
| Tarachand Singh                                                |   | 2011             |   | 20,000                  |   | -                      |   | -                           |   | -                            |   | -                                          |   | -                                               |   | 220                            |   | 20,220    |   |
| (Chief Financial Officer) (7)                                  |   | 2010             |   | 120,000                 |   | -                      |   | -                           |   | -                            |   | -                                          |   | -                                               |   | 960                            |   | 120,960   |   |
|                                                           |   |             |   |                    |   |                   |   |                        |   |                         |   |                                       |   |                                            |   |                           |   |      |   |

| 1.   | Represents fair value on the date of grant.  See Note B to the Consolidated Financial Statements included in our Form 10–K for the fiscal year ended May 31, 2011 for a discussion of the relevant assumptions used in calculating grant date fair value. |
|----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.   | Represents amounts matched in the Company’s 401(k) Plan. |
|----------------|----------------------------------------------------------------|

| 3.   | Dr. Ma has served as President and Chief Executive Officer since October 16, 2008. |
|----------------|------------------------------------------------------------------------------------|

| 4.   | Mr. Newton served as Chief Financial Officer from September 1, 2010 to September 8, 2011, and is currently Vice President of Finance and Controller. |
|----------------|------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.   | Dr. Hui was President and Chief Executive Officer from April 30, 2007 to October 15, 2008. |
|----------------|--------------------------------------------------------------------------------------------|

| 6.   | Mr. Barron has served as Chief Operating Officer of VasoHealthcare since April 1, 2010. |
|----------------|-----------------------------------------------------------------------------------------|

| 7.   | Mr. Singh was Chief Financial Officer from March 11, 2009 to August 26, 2010. |
|----------------|-------------------------------------------------------------------------------|

----

|               |   |   Option Awards                                         |    |  Stock Awards |                                                                |
|--------------------|--------|-------------------------------------------------------------------|---------|--------------------|---------------------------------------------------------------------|
| Name               |   | Number of Securities Underlying Unexercised Options - Exercisable |    |               | Number of Securities Underlying Unexercised Options - Unexercisable |   |   | Equity Incentive Plan Awards: Number of Underlying Unexercised Unearned Options |   |   | Option Exercise Price |   | Option Expiration Date |   | Number of Shares or Units of Stock That Have Not Vested |   |   | Market Value of Shares or Units of Stock That Have Not Vested |   |   | Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested |   |   | Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested |   |
| Jun Ma, PhD        |   |                                                              | 150,000 |               |                                                                |   | - |   |   |   | - |   |   | $ | 0.12 |   | 7/25/2017 |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |
|               |   |                                                              | 250,000 |               |                                                                |   | - |   |   |   | - |   |   | $ | 0.08 |   | 12/17/2014 |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |
|               |   |                                                              |    |               |                                                                |   |   |   |   |   |   |   |   |   |   |   |   |   |   | 500,000 |   |   | $ | 105,000 |   |   |   | - |   |   |   | - |   |
| Jonathan P. Newton |   |                                                              |    |               |                                                                |   |   |   |   |   |   |   |   |   |   |   |   |   |   | 150,000 |   |   | $ | 31,500 |   |   |   |   |   |   |   |   |   |
|               |   |                                                              |    |               |                                                                |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| John C.K. Hui, PhD |   |                                                              | 50,000  |               |                                                                |   | - |   |   |   | - |   |   | $ | 3.96 |   | 7/11/2011 |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |
|               |   |                                                              | 50,000  |               |                                                                |   | - |   |   |   | - |   |   | $ | 1.11 |   | 7/12/2014 |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |
|               |   |                                                              | 29,558  |               |                                                                |   | - |   |   |   | - |   |   | $ | 0.57 |   | 6/22/2015 |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |
|               |   |                                                              | 40,000  |               |                                                                |   | - |   |   |   | - |   |   | $ | 0.58 |   | 9/20/2015 |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |
|               |   |                                                              | 200,000 |               |                                                                |   | - |   |   |   | - |   |   | $ | 0.22 |   | 4/3/2016 |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |

----

|                 |   | Fees Earned or Paid in Cash |   | Stock Awards |   | Option Awards |   | Non-equity Incentive Plan Compensation |   | Nonqualified Deferred Compensation Earnings |   | All Other Compensation |   | Total   |   |
|----------------------|--------|-----------------------------|--------|--------------|--------|---------------|--------|----------------------------------------|--------|---------------------------------------------|--------|------------------------|--------|---------|--------|
| Name                 |   | ($)                         |   | ($)          |   | ($)           |   | ($)                                    |   | ($)                                         |   | ($)                    |   | ($)     |   |
| Simon Srybnik        |   | 4,500                       |   | 21,000       |   | -             |   | -                                      |   | -                                           |   | -                      |   | 25,500  |   |
| Behnam Movaseghi (1) |   | 7,500                       |   | 21,000       |   | -             |   | -                                      |   | -                                           |   | 50,000                 |   | 78,500  |   |
| Derek Enlander       |   | 12,000                      |   | 21,000       |   | -             |   | -                                      |   | -                                           |   | -                      |   | 33,000  |   |
| William Dempsey (2)  |   | 6,000                       |   | 21,000       |   | -             |   | -                                      |   | -                                           |   | 50,000                 |   | 77,000  |   |
| Peter Castle         |   | 14,500                      |   | 31,500       |   | -             |   | -                                      |   | -                                           |   | -                      |   | 46,000  |   |
| Edgar Rios (3)       |   | 1,500                       |   | 31,000       |   | -             |   | -                                      |   | -                                           |   | 297,500                |   | 330,000 |   |
| David Lieberman (3)  |   | 1,500                       |   | 31,000       |   | -             |   | -                                      |   | -                                           |   | 204,000                |   | 236,500 |   |
| Abraham Cohen        |   | 1,500                       |   | -            |   | -             |   | -                                      |   | -                                           |   | -                      |   | 1,500   |   |

| (1)   | During fiscal year 2011, Behnam Movaseghi received a grant of 116,279 shares of restricted common stock valued at $50,000 for consulting work outside of his duties as a director. |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2)   | During fiscal year 2011, William Dempsey received $50,000 for consulting work outside of his duties as a director. |
|-----------------|--------------------------------------------------------------------------------------------------------------------|

| (3)   | Edgar Rios and David Lieberman received 875,000 shares of restricted common stock valued at $297,500 and 600,000 shares of restricted common stock valued at $204,000, respectively, in conjunction with the engagement of Edgary Consultants, LLC as a consultant to the Company. |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

ITEM 12 - SECURITY 

----

| Name of Beneficial Owner                                    |   | Common Stock Beneficially Owned (1) |       |   | % of Common Stock (2) |   |
|-------------------------------------------------------------|--------|------------------------------------------|------------|--------|----------------------------|--------|
| Michael J. Beecher **                                       |   |                                     | 100,000    |   |                       |   | * |   |
| Peter Castle**                                              |   |                                     | 200,000    |   |                       |   | * |   |
| William Dempsey **                                          |   |                                     | 6,677,000  |   |                       |   | 4.36 | % |
| John C. K. Hui, PhD (3) **                                  |   |                                     | 1,492,214  |   |                       |   | * |   |
| David Lieberman **                                          |   |                                     | 1,324,200  |   |                       |   | * |   |
| Jun Ma, PhD **                                              |   |                                     | 2,045,834  |   |                       |   | 1.33 | % |
| Benham Movaseghi **                                         |   |                                     | 1,064,404  |   |                       |   | * |   |
| Jonathan Newton **                                          |   |                                     | 150,000    |   |                       |   | * |   |
| Edgar Rios **                                               |   |                                     | 1,475,000  |   |                       |   | * |   |
| Simon Srybnik (4) (5) **                                    |   |                                     | 55,738,318 |   |                       |   | 35.40 | % |
| Louis Srybnik (4) (5)                                       |   |                                     | 45,165,993 |   |                       |   | 28.71 | % |
|                                                        |   |                                     |       |   |                       |   |   |   |
| ** Directors and executive officers as a group (10 persons) |   |                                     | 70,266,970 |   |                       |   | 44.31 | % |
|                                                        |   |                                     |       |   |                       |   |   |   |
|                                                        |   |                                     |       |   |                       |   |   |   |

| 1.   | No officer or director owns more than one percent of the issued and outstanding common stock of the Company unless otherwise indicated.  Includes beneficial ownership of the following numbers of shares that may be acquired within 60 days of September 23, 2011 pursuant to a warrant awarded under the Securities Purchase Agreement with Kerns Manufacturing Corp. (“Kerns”), and stock options awarded under our stock plans: |
|----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                    |   | Stock   |   |      |   |      |   |
|-------------------------|--------|---------|--------|-----------|--------|-----------|--------|
|                    |   | Options |   | Warrants  |   | Total     |   |
| John C. K. Hui, PhD     |   | 369,558 |   |      |   | 369,558   |   |
| Jun Ma, PhD             |   | 400,000 |   |      |   | 400,000   |   |
| Behnam Movaseghi        |   | 350,000 |   |      |   | 350,000   |   |
| Simon Srybnik           |   | 150,000 |   | 4,285,714 |   | 4,435,714 |   |
| Directors and executive |   |    |   |      |   |      |   |
| officers as a group     |   |    |   |      |   | 5,555,272 |   |

| 2.   | Applicable percentages are based on 148,932,104 shares of common stock outstanding as of September 23, 2011, adjusted as required by rules promulgated by the SEC. |
|----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.   | Includes 789,322 shares that are held in a trust for the benefit of Dr. Hui’s child. Dr. Hui and his wife are the trustees of this trust. |
|----------------|-------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.   | Simon Srybnik and his brother Louis Srybnik are the sole directors and the Chairman of the Board and President, respectively of Kerns, which is the record holder of 25,714,286 shares (of which 4,285,714 shares are not issuable until a restricted warrant is exercised). They are the sole shareholders of Kerns, each holding 50% of the shares.  The reporting persons, accordingly, share voting and dispositive powers over the 21,428,572 shares held by Kerns and share dispositive power over the 4,285,714 shares underlying the restricted warrant. As a result, they may be deemed to be the co-beneficial owners of an aggregate of 25,714,286 shares.  Mr. Simon Srybnik also holds sole dispositive power over 150,000 sharesunderlying the option he was granted upon being appointed to the Board of Directors, 598,125 shares of common stock awarded him as of May 31, 2011, as well as 11,460,900 additional shares of common stock.  Mr. Louis Srybnik holds sole dispositive power over 1,636,700 shares of common stock. |
|----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.   | Simon Srybnik and his brother Louis Srybnik are the sole directors and officers of Living Data Technology Corporation (“Living Data”). They also each own 35% of the outstanding shares of Living Data.  The reporting persons, accordingly, share voting and dispositive powers over the 17,815,007 shares of our common stock owned by Living Data and, as a result, may be deemed to be the co-beneficial owners thereof. |
|----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Plan category           |   | (a) Number of securities to be issued upon exercise of outstanding options, warrants and rights |      |   | (b) Weighted-average exercise price of outstanding options, warrants and rights |   |   | (c) Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) |   |
|-------------------------|--------|------------------------------------------------------------------------------------------------------|-----------|--------|--------------------------------------------------------------------------------------|--------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
|                    |   |                                                                                                 |      |   |                                                                                 |   |   |                                                                                                                                                 |   |
| Equity Compensation     |   |                                                                                                 |      |   |                                                                                 |   |   |                                                                                                                                                 |   |
| plans approved by       |   |                                                                                                 |      |   |                                                                                 |   |   |                                                                                                                                                 |   |
| security holders        |   |                                                                                                 | 1,489,776 |   |                                                                                 | $      | 0.17   |                                                                                                                                                 |   |   | 785,224 |   |
|                    |   |                                                                                                 |      |   |                                                                                 |   |   |                                                                                                                                                 |   |   |   |   |
| Equity Compensation     |   |                                                                                                 |      |   |                                                                                 |   |   |                                                                                                                                                 |   |   |   |   |
| plans not approved      |   |                                                                                                 |      |   |                                                                                 |   |   |                                                                                                                                                 |   |   |   |   |
| by security holders (1) |   |                                                                                                 | 7,994,714 |   |                                                                                 | $      | 0.16   |                                                                                                                                                 |   |   | 920,000 |   |
|                    |   |                                                                                                 |      |   |                                                                                 |   |   |                                                                                                                                                 |   |   |   |   |
| Total                   |   |                                                                                                 | 9,484,490 |   |                                                                                 |   |   |                                                                                                                                                 |   |   | 1,705,224 |   |
|                    |   |                                                                                                 |      |   |                                                                                 |   |   |                                                                                                                                                 |   |   |   |   |
|                    |   |

| (1) | Includes 4,659,714 shares issuable upon exercise of options and warrants, 250,000 shares issuable under a consulting agreement with a former director, and 3,085,000 shares of restricted common stock granted, but unissued, under the 2010 Plan.  The weighted average exercise price of the options and warrants is $0.16, and the exercise price for the stock grants is zero.  920,000 shares remain available for future grants under the 2010 Plan. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

ITEM 13 - CERTAIN 

----

|            |   | Shares |    |
|-----------------|--------|--------|---------|
| William Dempsey |   |   | 65,568  |   |
| David Lieberman |   |   | 6,217   |   |
| Simon Srybnik   |   |   | 114,143 |   |

| ·   | a director who is, or at any time during the past three years was, employed by us; |
|--------------------|------------------------------------------------------------------------------------|

| ·   | a director who accepted or who has a family member who accepted any compensation from us in excess of $100,000 during any period of twelve consecutive months within the three years preceding the determination of independence, other than the following: |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | compensation for service on the Board of Directors or any committee thereof; |
|--------------------|------------------------------------------------------------------------------|

| ·   | compensation paid to a family member who is one of our employees (other than an executive officer); or |
|--------------------|--------------------------------------------------------------------------------------------------------|

| ·   | under a tax-qualified retirement plan, or non-discretionary compensation; |
|--------------------|---------------------------------------------------------------------------|

| ·   | a director who is a family member of an individual who is, or at any time during the past three years was, employed by us as an executive officer; |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | a director who is, or has a family member who is, a partner in, or a controlling stockholder or an executive officer of, any organization to which we made, or from which we received, payments for property or services in the current or any of the past three fiscal years that exceed 5% of the recipient's consolidated gross revenues for that year, or $200,000, whichever is more, other than the following: |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | payments arising solely from investments in our securities; or |
|--------------------|----------------------------------------------------------------|

| ·   | payments under non-discretionary charitable contribution matching programs; |
|--------------------|-----------------------------------------------------------------------------|

| ·   | a director who is, or has a family member who is, employed as an executive officer of another entity where at any time during the past three years any of our executive officers served on the compensation committee of such other entity; or |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | a director who is, or has a family member who is, a current partner of our outside auditor, or was a partner or employee of our outside auditor who worked on our audit at any time during any of the past three years. |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

ITEM 14 - PRINCIPAL 

----

|       |   | 2011   |    |   | 2010   |   |
|------------|--------|--------|---------|--------|--------|--------|
| Audit Fees |   | $      | 122,750 |   |   | $      | 75,000 |   |
| Tax Fees   |   |   | 15,000  |   |   |   | 15,000 |   |
| Total      |   | $      | 137,750 |   |   | $      | 90,000 |   |

----

|   | VASOMEDICAL, INC.                          |
|--------|--------------------------------------------|
|   |                                       |
|   | By: /s/ Jun Ma                             |
|   | Jun Ma                                     |
|   | President, Chief Executive Officer         |
|   | and Director (Principal Executive Officer) |

| /s/Jun Ma                                                                                                                                                                             | President, Chief Executive Officer and Director       |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------|
| Jun Ma                                                                                                                                                                                | (Principal Executive Officer)                         |
|                                                                                                                                                                                  |                                                  |
| /s/ Simon Srybnik                                                                                                                                                                     | Chairman of the Board                                 |
| Simon Srybnik                                                                                                                                                                         |                                                  |
|   th                                                                                                                                                                             |                                                  |
| /s/ Michael J. Beecher                                                                                                                                                                | Chief Financial Officer (Principal Financial Officer) |
| Michael J. Beecher                                                                                                                                                                    |                                                  |
|                                                                                                                                                                                  |                                                  |
| /s/ David Lieberman                                                                                                                                                                   | Vice Chairman of the Board and Director               |
| David Lieberman                                                                                                                                                                       |                                                  |
|                                                                                                                                                                                  |                                                  |
| /s/ Peter Castle                                                                                                                                                                      | Director                                              |
| Peter Castle                                                                                                                                                                          |                                                  |
|                                                                                                                                                                                  |                                                  |
|                                 | Director                                              |
| William Dempsey                                                                                                                                                                       |                                                  |
|                                                                                                                                                                                  |                                                  |
| /s/ Behnam Movaseghi                                                                                                                                                                  | Director                                              |
| Behnam Movaseghi                                                                                                                                                                      |                                                  |
|                                                                                                                                                                                  |                                                  |
| /s/ Edgar Rios                                                                                                                                                                        | Director                                              |
| Edgar Rios                                                                                                                                                                            |                                                  |

----